High activity iodine 125 endocurietherapy for recurrent skull base tumors

P. Pradeep Kumar, Roger R. Good, Lyal G. Leibrock, John R. Mawk, Anthony James Yonkers, Frederic P. Ogren

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Experience with endocurietherapy of skull base tumors is reviewed. We present our cases of recurrent pituitary hemangiopericytoma, radiation‐induced recurrent meningioma, recurrent clival chordoma, recurrent nasopharyngeal cancer involving the cavernous sinus, and recurrent parotid carcinoma of the skull base which were all successfully retreated with high‐activity 125iodine (I‐125) permanent implantation.

Original languageEnglish (US)
Pages (from-to)1518-1527
Number of pages10
JournalCancer
Volume61
Issue number8
DOIs
StatePublished - Jan 1 1988

Fingerprint

Skull Base
Iodine
Nasopharyngeal Neoplasms
Hemangiopericytoma
Chordoma
Cavernous Sinus
Meningioma
Neoplasms
Carcinoma

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Kumar, P. P., Good, R. R., Leibrock, L. G., Mawk, J. R., Yonkers, A. J., & Ogren, F. P. (1988). High activity iodine 125 endocurietherapy for recurrent skull base tumors. Cancer, 61(8), 1518-1527. https://doi.org/10.1002/1097-0142(19880415)61:8<1518::AID-CNCR2820610807>3.0.CO;2-D

High activity iodine 125 endocurietherapy for recurrent skull base tumors. / Kumar, P. Pradeep; Good, Roger R.; Leibrock, Lyal G.; Mawk, John R.; Yonkers, Anthony James; Ogren, Frederic P.

In: Cancer, Vol. 61, No. 8, 01.01.1988, p. 1518-1527.

Research output: Contribution to journalArticle

Kumar, PP, Good, RR, Leibrock, LG, Mawk, JR, Yonkers, AJ & Ogren, FP 1988, 'High activity iodine 125 endocurietherapy for recurrent skull base tumors', Cancer, vol. 61, no. 8, pp. 1518-1527. https://doi.org/10.1002/1097-0142(19880415)61:8<1518::AID-CNCR2820610807>3.0.CO;2-D
Kumar, P. Pradeep ; Good, Roger R. ; Leibrock, Lyal G. ; Mawk, John R. ; Yonkers, Anthony James ; Ogren, Frederic P. / High activity iodine 125 endocurietherapy for recurrent skull base tumors. In: Cancer. 1988 ; Vol. 61, No. 8. pp. 1518-1527.
@article{c66c897f4be44dce91f1991f15efd14c,
title = "High activity iodine 125 endocurietherapy for recurrent skull base tumors",
abstract = "Experience with endocurietherapy of skull base tumors is reviewed. We present our cases of recurrent pituitary hemangiopericytoma, radiation‐induced recurrent meningioma, recurrent clival chordoma, recurrent nasopharyngeal cancer involving the cavernous sinus, and recurrent parotid carcinoma of the skull base which were all successfully retreated with high‐activity 125iodine (I‐125) permanent implantation.",
author = "Kumar, {P. Pradeep} and Good, {Roger R.} and Leibrock, {Lyal G.} and Mawk, {John R.} and Yonkers, {Anthony James} and Ogren, {Frederic P.}",
year = "1988",
month = "1",
day = "1",
doi = "10.1002/1097-0142(19880415)61:8<1518::AID-CNCR2820610807>3.0.CO;2-D",
language = "English (US)",
volume = "61",
pages = "1518--1527",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "8",

}

TY - JOUR

T1 - High activity iodine 125 endocurietherapy for recurrent skull base tumors

AU - Kumar, P. Pradeep

AU - Good, Roger R.

AU - Leibrock, Lyal G.

AU - Mawk, John R.

AU - Yonkers, Anthony James

AU - Ogren, Frederic P.

PY - 1988/1/1

Y1 - 1988/1/1

N2 - Experience with endocurietherapy of skull base tumors is reviewed. We present our cases of recurrent pituitary hemangiopericytoma, radiation‐induced recurrent meningioma, recurrent clival chordoma, recurrent nasopharyngeal cancer involving the cavernous sinus, and recurrent parotid carcinoma of the skull base which were all successfully retreated with high‐activity 125iodine (I‐125) permanent implantation.

AB - Experience with endocurietherapy of skull base tumors is reviewed. We present our cases of recurrent pituitary hemangiopericytoma, radiation‐induced recurrent meningioma, recurrent clival chordoma, recurrent nasopharyngeal cancer involving the cavernous sinus, and recurrent parotid carcinoma of the skull base which were all successfully retreated with high‐activity 125iodine (I‐125) permanent implantation.

UR - http://www.scopus.com/inward/record.url?scp=0023931363&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023931363&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(19880415)61:8<1518::AID-CNCR2820610807>3.0.CO;2-D

DO - 10.1002/1097-0142(19880415)61:8<1518::AID-CNCR2820610807>3.0.CO;2-D

M3 - Article

VL - 61

SP - 1518

EP - 1527

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 8

ER -